Boehringer-Ingelheim has announced that Vaxxilive® Cocci 3 will be available for broilers superseding Hatchpak® Cocci III.
The vaccine contains precocious Eimeria species that affect broilers. Precocious strains do not produce the same level of tissue damage as conventional strains as they only undergo one cycle of asexual reproduction (schizogony). Boehringer-Ingelheim has positioned the vaccine for year-ground use as an alternative to feed additive anticoccidial drugs.
In announcing the launch, Dr. Rick Phillips, Director for Key Account Veterinarians stated, “As with any vaccination, choosing a product is only half the battle.” He added, “Our experienced and knowledgeable field team provides industry-leading support to producers, regularly visiting them to review vaccination protocols, and to create and maintain comprehensive poultry health programs.”